Frontlight ResearchEarly access
Trial site
Bethune first hospital of jilin university
- 4running trials
- 5closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Metastatic breast cancer2 trials
- Ankylosing spondylitis1 trial
- Brain aneurysm1 trial
- Chronic lymphocytic leukaemia1 trial
- Liver and biliary tract cancer1 trial
- Psoriasis1 trial
- Rheumatoid arthritis1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Phase 2/31 trial
- Status
- Completed4 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Shanghai Junshi Bioscience Co., Ltd.2 trials
- Beijing InnoCare Pharma Tech Co., Ltd.1 trial
- Eucure (Beijing) Biopharma Co., Ltd1 trial
- Genor Biopharma Co., Ltd.1 trial
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd1 trial
- and 3 more
Running trials
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
Recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic lymphocytic leukaemia1 recruiting
- Metastatic breast cancer1 recruiting
- Rheumatoid arthritis1 recruiting
Closed trials
Completed
A Clinical Study of JS005 in Patients With Ankylosing Spondylitis
Completed
Withdrawn
A Study to Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC
Completed
GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Completed
A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China
Site data: ClinicalTrials.govUpdated 17 Nov 2026